Astellas Starts Phase 3 Trial of Setidegrasib vs Docetaxel in KRAS G12D Lung Cancer
Astellas Starts Phase 3 Trial of Setidegrasib vs Docetaxel in KRAS G12D Lung Cancer The Clinical Trial Vanguard
Онкология
🎗️Лента новостей
Онкология
FDA Advisory Panel Votes 7-2 to Support Galleri Multi-Cancer Blood Test
FDA Advisory Panel Votes 7-2 to Support Galleri Multi-Cancer Blood Test The Clinical Trial Vanguard
Онкология
В Китае разработали модель ИИ для скрининга рака пищевода
В Китае разработали модель ИИ для скрининга рака пищевода СБ. Беларусь
Онкология
Смертельная опухоль выстроит живой щит: найденный механизм полностью ослепляет иммунитет
Смертельная опухоль выстроит живой щит: найденный механизм полностью ослепляет иммунитет Правда.Ру
Онкология
Известный американский телеведущий умер от рака
Известный американский телеведущий умер от рака NEWS.ru
Онкология
Cancer incidence remains higher in people with type 2 diabetes, with the gap widening in recent years
A nationwide study presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2 has found that people with type 2 diabetes (T2D) have a higher risk of developing cancer. Cancer incidence has risen more among people with T2D than among those without…
Онкология
Awareness, early diagnosis boost bladder cancer treatment demand
Awareness, early diagnosis boost bladder cancer treatment demand healthcareasiamagazine.com
Онкология
Tumor digital twins took months to build—AI now drafts them in minutes
Until now, building a digital model of a tumor required scientists to review extensive literature, train in specialized software and master multiple programming languages. From start to finish, the process often took months, if not years, of specialized work.
Онкология
Scientists find the gene that drives T-cell exhaustion, revealing new strategy to improve immune responses
Immunotherapy, which uses a patient's immune system to treat disease, has increased survival for some adults and children with cancer. However, it has had limited success against many pediatric solid tumors, in part because T cells can become functionally impaired or "exhausted." St. Jude Children's Research Hospital…
Онкология
Make a Donation Today to Help Support Amazing Cancer Researchers - Conquer Cancer, the ASCO Foundation
Make a Donation Today to Help Support Amazing Cancer Researchers - Conquer Cancer, the ASCO Foundation Oncodaily
Онкология
8-year-old battles rare brain cancer diagnosis: 'Give us a little more time'
8-year-old battles rare brain cancer diagnosis: 'Give us a little more time' ABC11 News
🎗️
Онкология
Российские ученые разработали вакцину для персонализированной терапии рака легкого
Российские ученые разработали вакцину для персонализированной терапии рака легкого Новости Беларуси | БелТА
Онкология
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research PR Newswire
Онкология
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research Yahoo Finance
Онкология
Российские ученые разработали вакцину для персонализированной терапии рака легкого
Российские ученые разработали вакцину для персонализированной терапии рака легкого Новости Беларуси | БелТА